Literature DB >> 6931632

Amsacrine (AMSA).

B F Issell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6931632     DOI: 10.1016/s0305-7372(80)80017-x

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  8 in total

Review 1.  Antineoplastic drugs in 1990. A review (Part II).

Authors:  D J Black; R B Livingston
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

Review 2.  Cancer chemotherapy: past, present, and future--Part I.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1984-08       Impact factor: 1.798

3.  Dose-dependent skin ulcers in mice treated with DNA binding antitumor antibiotics.

Authors:  M J Soble; R T Dorr; P Plezia; S Breckenridge
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

4.  Phase I and II study of AMSA in childhood tumours.

Authors:  A Goldman; J S Malpas
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

5.  Five-day 4'-(9-acridinylamino)methanesulphon-m-anisidide and intermediate-dose cytosine arabinoside in high-risk relapsing or refractory acute myeloid leukemia.

Authors:  M Freund; S Giller; F Hinrichs; A Baars; J Meran; A Körfer; H Link; H Poliwoda
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

6.  A phase I and II study of m-AMSA in acute leukaemia.

Authors:  M L Slevin; M S Shannon; H G Prentice; A J Goldman; T A Lister
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

7.  The tissue localization of m-AMSA and its effect on thymidine incorporation in various tissues in vivo.

Authors:  B Hellman; B S Andersson; P Slanina; A Mohammed; I Brandt; M Beran
Journal:  Med Oncol Tumor Pharmacother       Date:  1986

8.  Clonal variation in the sensitivity of B16 melanoma to m-AMSA.

Authors:  T C Stephens; J H Peacock
Journal:  Br J Cancer       Date:  1982-06       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.